UPC Analytics
DEEN
Übersicht · Eingereicht: 13. Dez. 2024

UPC_CoA_810/2024

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

BerufungenHauptberufungCourt of AppealGenericCase Closed
ÜbersichtEntscheidungenZitateDokumenteZeitverlauf
Parteien

Kläger

  • Curio Bioscience Inc.
Vertreter: Tilman Mueller-Stoy (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)

Beklagte

  • 10x Genomics, Inc.
Vertreter: Cameron Marshall (Carpmaels & Ransford LLP); Agathe Michel-De Cazotte (Carpmaels & Ransford LLP)
Richter
  • Emmanuel Gougé
Patente
  • EP2697391
  • EP 2 697 391 B1
CPC-Codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sektor: Biotechnology

Ausgang
Abgewiesen
Eingereicht: 13. Dez. 2024
Erste Entscheidung: —
Sprache: English

The Court of Appeal (standing judge) dismissed Curio Bioscience Inc.'s application for suspensive effect (R. 223.4 RoP) of a Düsseldorf Local Division order requiring Curio to provide security for costs of EUR 200,000 in favour of claimant 10x Genomics Inc. The standing judge held that Curio had not established 'extreme urgency' as required under R. 223 RoP, which is a condition for a standing-judge decision without hearing the respondent.

Im UPC-Register öffnen